K811953 is an FDA 510(k) clearance for the IMMOPHASE INSULIN (125I) RADIOASSAY. Classified as Radioimmunoassay, Immunoreactive Insulin (product code CFP), Class I - General Controls.
Submitted by Corning Medical & Scientific (Mchenry, US). The FDA issued a Cleared decision on July 23, 1981 after a review of 15 days - a notably fast clearance cycle.
This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1405 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Corning Medical & Scientific devices